World-first melanoma blood test detects early stages of deadly skin cancer in 81.5% of cases.
Melanoma is usually identified visually, and suspected lesions are excised. Researchers in Australia have developed the world’s first blood test to detect melanoma before it spreads through the body. The test works by detecting autoantibodies to fight melanoma.
If clinical trials prove successful, a pharmaceutical company would need to make the test commercially available.
A diagnostic autoantibody signature for primary cutaneous melanoma.